Faculty Recruitment – NEIDL Boston University

 The National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University (BU), one of only two national maximum containment facilities, is embarking on an exciting new phase of scientific growth, with the recruitment of multiple faculty members at all ranks. Successful candidates will hold a faculty position in one or more academic departments across BU, usually within the Chobanian & Avedisian School of Medicine, the College of Arts & Sciences, or the College of Engineering.

NEIDL is committed to global impact, transforming high-consequence pathogen research to create life-saving technologies and innovations. With programs in immunology, virology, bacteriology, host pathogenesis, and genetic epidemiology, as well as established international collaborations, NEIDL faculty conduct research to define, prevent, and treat diseases caused by pathogens with pandemic potential. 

Situated within the vibrant academic, medical, and biopharma ecosystem of Boston, NEIDL contributes to a dynamic infectious diseases hub at BU, alongside numerous global infectious disease departments on the Medical Campus and active collaborations with universities and biotech throughout the Boston area. 

NEIDL provides an unparalleled research environment with state-of-the-art laboratory facilities encompassing all biosafety levels (BSL), up to and including BSL-4, extensive animal housing facilities, aerobiology labs, and high-containment insectaries. Faculty members have access to an array of technology platforms within NEIDL, including advanced microscopy, flow cytometry, biocontainment in vivo imaging, high-throughput tissue staining, spatial transcriptomics, and fluid microrobotics. University Centers across the BU campus provide investigators access to additional technologies, such as stem cell/organoid technologies at the Center for Regenerative Medicine, shared and core facilities in Photonics, Center for Computing & Data Sciences, CARB-X (the global antibacterial innovation accelerator), and a Cryo-EM facility.